Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
2011
|
| _version_ | 1797052777992552448 |
|---|---|
| author | Andrews, MD Fish, P Blagg, J Brabham, T Brennan, P Bridgeland, A Brown, A Bungay, P Conlon, K Edmunds, N af Forselles, K Gibbons, C Green, M Hanton, G Holbrook, M Jessiman, A McIntosh, K McMurray, G Nichols, C Root, J Storer, R Sutton, MR Ward, R Westbrook, D Whitlock, G |
| author_facet | Andrews, MD Fish, P Blagg, J Brabham, T Brennan, P Bridgeland, A Brown, A Bungay, P Conlon, K Edmunds, N af Forselles, K Gibbons, C Green, M Hanton, G Holbrook, M Jessiman, A McIntosh, K McMurray, G Nichols, C Root, J Storer, R Sutton, MR Ward, R Westbrook, D Whitlock, G |
| author_sort | Andrews, MD |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T18:35:26Z |
| format | Journal article |
| id | oxford-uuid:0b0e145b-6f13-4841-87fa-879d28e64ed5 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T18:35:26Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:0b0e145b-6f13-4841-87fa-879d28e64ed52022-03-26T09:27:34Z Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinenceJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0b0e145b-6f13-4841-87fa-879d28e64ed5Symplectic Elements at Oxford2011Andrews, MDFish, PBlagg, JBrabham, TBrennan, PBridgeland, ABrown, ABungay, PConlon, KEdmunds, Naf Forselles, KGibbons, CGreen, MHanton, GHolbrook, MJessiman, AMcIntosh, KMcMurray, GNichols, CRoot, JStorer, RSutton, MRWard, RWestbrook, DWhitlock, G |
| spellingShingle | Andrews, MD Fish, P Blagg, J Brabham, T Brennan, P Bridgeland, A Brown, A Bungay, P Conlon, K Edmunds, N af Forselles, K Gibbons, C Green, M Hanton, G Holbrook, M Jessiman, A McIntosh, K McMurray, G Nichols, C Root, J Storer, R Sutton, MR Ward, R Westbrook, D Whitlock, G Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence |
| title |
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence |
| title_full |
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence |
| title_fullStr |
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence |
| title_full_unstemmed |
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence |
| title_short |
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence |
| title_sort | pyrimido 4 5 d azepines as potent and selective 5 ht2c receptor agonists design synthesis and evaluation of pf 3246799 as a treatment for urinary incontinence |
| work_keys_str_mv | AT andrewsmd pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT fishp pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT blaggj pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT brabhamt pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT brennanp pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT bridgelanda pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT browna pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT bungayp pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT conlonk pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT edmundsn pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT afforsellesk pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT gibbonsc pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT greenm pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT hantong pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT holbrookm pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT jessimana pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT mcintoshk pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT mcmurrayg pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT nicholsc pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT rootj pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT storerr pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT suttonmr pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT wardr pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT westbrookd pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence AT whitlockg pyrimido45dazepinesaspotentandselective5ht2creceptoragonistsdesignsynthesisandevaluationofpf3246799asatreatmentforurinaryincontinence |